ArticleEuropean journal of medical research2026
Therapeutic potential of CDK8 inhibitor combined with sorafenib for hepatocellular carcinoma: mechanistic insights and in vitro validation.
Li Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.